Post by Texas A&M Health Science Center

Innovative research is shifting the outlook on neurodegenerative care. Studies show that specific properties in nicotine may help slow cognitive decline, offering a promising new avenue for managing conditions like Alzheimer’s and Parkinson’s disease. Dr. Ursula Winzer-Serhan and Dr. Rahul Srinivasan in the Texas A&M University Naresh K. Vashisht College of Medicine are both investigating nicotine’s neuroprotective effects. While their findings are encouraging, they stress the important difference between clinical research and commercial products, and still caution against smoking. Learn more about their work: tx.ag/brainnicotine